Joe Cook Jr
Executive Chairman at Appello Pharmaceuticals
United States
Overview
Work Experience
Managing Director and Founder
2003 - Current
Involved in assessing new venture opportunities and assisting management in growing life science based companies.
Mountain Group Partners is an investor dedicated to investing in and actively guiding transformation businesses in the Life Science.
Executive Chairman
2018
Member College of Engineering Advisory Board
1986 - 2022
Provide advice and counsel to the Dean of the College of Engineering at the University of Tennessee on a wide range of academic, financial and strategic issues.
University of Tennessee School of Architecture and Design is a college of diverse people who celebrate differences.
Director
2004 - 2020
Chairman of Mercy Multiplied, International
Director
2001 - 2016
Served as an independent director for Corcept Therapeutics, Inc., a publicly traded company developing medicines for people with Cushings Syndrome and cancer.
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Raised $119,089,479.00 from Sutter Hill Ventures, Alta Partners, Longitude Capital, Alta Partners, Sutter Hill Ventures and Paperboy Ventures.
Founder and Director
1998 - 2015
Founder and Chairman of the Board from 1998 until 2011.
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Raised $634,000,000.00 from Polaris Partners.
Strategic Advisory Board
2005 - 2015
Former member of a strategy board for Elanco that provided independent advice and counsel to Elanco Products Company a wholly owned division of Eli Lilly & Co. Elanco is focused on developing, manufacturing, and marketing products to serve the animal health and companion animal markets.
Chairman of the Board-Retired
1998 - 2009
Provided overall Board leadership for Amylin Pharmaceuticals, Inc. a publically traded company developing, manufacturing and marketing medicines for people with diabetes.
Chairman and CEO-Retired
1998 - 2003
As CEO of Amylin form 1998 to 2003, I was directly involved in leading the company through a challenging time which started with clinical trials that did not meet expectations. Eventually the company was able to complete a successful development plan which led to approval and marketing of three products to treat people with diabetes.
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.
Trustee
1988 - 2004
Provided overall trustee advice, counsel and support for a theological seminary focused on educating men and women to serve as pastors in protestant churches.
Group Vice President
1965 - 1993
Group Vice President-Retired
1965 - 1993
Responsible for global operations of Eli Lilly & Co. including manufacturing, production planning, purchasing, engineering, quality assurance, facilities, new product development and launch preparation.
Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.
Raised $6,500,000.00.